We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-39.17%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$101M
AUM Growth
-$73.3M
Cap. Flow
+$10.2M
Cap. Flow %
10.1%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
Reduced
Closed
3

Top Buys

Rank Stock Value
1
GENB
Generate Biomedicines
GENB
+$21M

Top Sells

Rank Stock Value
1
RBRK icon
Rubrik
RBRK
+$6.9M
2
EPSN icon
Epsilon Energy
EPSN
+$3.9M
3
RPTX
Repare Therapeutics
RPTX
+$31.9K

Sector Composition

Rank Sector Weight
1 Financials 65.17%
2 Healthcare 26.96%
3 Technology 7.88%
4 Energy 0%

No holdings matched the selected filter criteria.

Similar funds

Harbourvest Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Harbourvest Partners held 8 positions worth $101M, down 42% from $174M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Harbourvest Partners deployed $10.2M of net new capital in Q1 2026, opening 1 new position. Its largest new stake was Generate Biomedicines: 1,722,210 shares worth $21.5M.

By sector, the portfolio is most concentrated in Financials at 65% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the most notable exit was Rubrik, an estimated $6.9M sold.

  • Harbourvest Partners's largest Q1 2026 buy was Generate Biomedicines: 1,722,210 shares worth $21.5M.
  • Harbourvest Partners fully exited Rubrik in Q1 2026, selling an estimated $6.9M.
  • Harbourvest Partners's ten largest holdings make up 100% of its $101M portfolio in Q1 2026.
  • Harbourvest Partners opened 1 new position and closed 3 in Q1 2026.
  • Harbourvest Partners's portfolio value fell 42% quarter-over-quarter to $101M.

Based on Harbourvest Partners's 13F filing for Q1 2026, filed 15 May 2026.